SKI Market

Indian Indices

Nifty

25,879.15 3.35
(0.01%)

Sensex

84,478.67 12.16
( 0.01%)

Bank Nifty

58,381.95 107.30
( 0.18%)

Nifty IT

36,679.50 -175.90
( -0.48%)

Global Indices

Nasdaq

48,279.16 330.20
(0.69%)

Dow Jones

6,872.70 5.09
(0.07%)

Hang Seng

51,206.70 143.39
(0.28%)

Nikkei 225

9,816.37 -95.05
(-0.96%)

Forex

USD-INR

88.68 0.06
(0.07%)

EUR-INR

102.52 0.03
(0.03%)

GBP-INR

116.74 0.13
(0.11%)

JPY-INR

0.58 0.00
(-0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5600262

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.62

122773.15

EPS(TTM)

Face Value()

Div & Yield %

64.35

1.05

Back

vaxtex cotfab ltd

Vaxtex Cotfab reports standalone net profit of Rs 0.57 crore in the September 2025 quarter

Nov 12,2025

Net profit of Vaxtex Cotfab reported to Rs 0.57 crore in the quarter ended September 2025 as against net loss of Rs 0.12 crore during the previous quarter ended September 2024. Sales reported to Rs 2.29 crore in the quarter ended September 2025. There were no Sales reported during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2.29	0	0
OPM %	-4.80	0	-
PBDT	0.61	-0.11	LP
PBT	0.60	-0.12	LP
NP	0.57	-0.12	LP

25,879.15 3.35 (0.01%)

84,478.67 12.16 ( 0.01%)

58,381.95 107.30 ( 0.18%)

36,679.50 -175.90 ( -0.48%)

48,279.16 330.20 (0.69%)

6,872.70 5.09 (0.07%)

51,206.70 143.39 (0.28%)

9,816.37 -95.05 (-0.96%)

88.68 0.06 (0.07%)

102.52 0.03 (0.03%)

116.74 0.13 (0.11%)

0.58 0.00 (-0.30%)